Walmart recalls apple juice sold in 25 states due to arsenic concerns

Washington — Walmart has recalled nearly 10,000 cases of apple juice sold in stores across the U.S. that were found to contain potentially harmful levels of inorganic arsenic.

The U.S. Food and Drug Administration gave the recall a more urgent classification Friday after making its original announcement Aug. 15. The new classification said the affected product may temporarily cause adverse health consequences but is unlikely to cause serious or irreversible medical issues.

The recall applies to 9,535 cases of Great Value brand apple juice sold in 25 states, Puerto Rico and the District of Columbia. Florida-based manufacturer Refresco Beverages US Inc. voluntarily recalled the contaminated six-packs of 8-ounce juice bottles after discovering levels of the chemical contaminant that exceeded industry standards.

A spokesperson for Refresco didn't immediately respond to emails seeking comment Sunday.

"The health and safety of our customers is always a top priority," Walmart spokesperson Molly Blakeman said in a statement. "We have removed this product from our impacted stores and are working with the supplier to investigate."

Very low levels of inorganic and organic arsenic are found in many food products, according to the National Institutes of Health. Testing is routine, as slightly elevated levels of either form can cause symptoms such as vomiting, abdominal pain, diarrhea, numbness and muscle cramping.

Inorganic arsenic is more toxic to humans than the naturally occurring form of the mineral arsenic, and the health effects from exposure are more severe, according to the FDA. The Environmental Protection Agency has labeled inorganic arsenic a carcinogen, or a substance that causes cancer.

Levels found in the recalled apple juice bottles are low enough that the FDA doesn't expect them to cause such severe health consequences.

The FDA hasn't shared reports of possible illnesses associated with the apple juice recall.

These states are affected, along with Washington, D.C. and Puerto Rico, the FDA says:

Alabama, Connecticut, Delaware, Florida, Georgia, Illinois, Indiana, Kentucky, Massachusetts, Maryland, Maine, Michigan, Mississippi, North Carolina, New Hampshire, New Jersey, New York, Ohio, Pennsylvania, Rhode Island South Carolina, Tennessee, Virginia, Vermont, West Virginia